Fig. 9From: Multiscale modeling reveals angiogenesis-induced drug resistance in brain tumors and predicts a synergistic drug combination targeting EGFR and VEGFR pathwaysPrognostic value of EGFR and VEGFR genes for glioma patients. a K-M survival analysis of EGFR and VEGFR genes in the CGGA dataset. b Time-dependent ROC curves with respect to the 1-year, 3-year and 5-year survival rates of glioma patients in the CGGA dataset. c K-M survival analysis of EGFR and VEGFR genes in the TCGA dataset. d Time-dependent ROC curves with respect to the 1-year, 3-year and 5-year survival rates of glioma patients in TCGA dataset. The CGGA dataset and TCGA dataset of glioma patients were used for training and validation, respectivelyBack to article page